Surgical Interventions Compared for Children, Teens With Kidney Stones
By Elana Gotkine HealthDay Reporter
Medically reviewed by Drugs.com
via HealthDayWEDNESDAY, Aug. 13, 2025 -- In two studies published online July 22 in JAMA Network Open, surgical interventions are compared for children and adolescents with kidney stones.
Gregory E. Tasian, M.D., from The Children's Hospital of Philadelphia, and colleagues compared stone clearance and patient-reported outcomes among 1,142 children and adolescents (aged 8 to 21 years) after ureteroscopy or shockwave lithotripsy in a nonrandomized clinical trial. A total of 124 urologists treated 1,069 and 197 kidneys or ureters with ureteroscopy and shockwave lithotripsy, respectively (953 and 189 patients, respectively). The researchers found that stone clearance occurred in 71.2 and 67.5 percent of patients who underwent ureteroscopy and shockwave lithotripsy, respectively, a difference that was not statistically significant. Ureteroscopy resulted in greater pain interference and urinary symptoms one week after surgery compared with shockwave lithotripsy.
Jonathan S. Ellison, M.D., from the Medical College of Wisconsin in Milwaukee, and colleagues compared clinical and patient-reported outcomes for percutaneous nephrolithotomy versus ureteroscopy in 1,039 children and adolescents with kidney and/or ureteral stones. Overall, 126 urologists performed percutaneous nephrolithotomy for 98 kidneys and/or ureters and ureteroscopy for 1,069. The researchers found that stone clearance was 67.2 and 73.4 percent for percutaneous nephrolithotomy and ureteroscopy, respectively, a difference that was not statistically significant. For stones larger than 15 mm, stone clearance was 94.0 and 55.0 percent for percutaneous nephrolithotomy and ureteroscopy, respectively, a difference that was statistically significant. At one week after surgery, percutaneous nephrolithotomy was associated with significantly lower pain intensity, pain interference, psychological stress experience, sleep disturbance, and urinary symptoms.
"Our findings provide new information that allow for tailored approaches to kidney stone treatment for children and their families," Tasian said in a statement.
Several authors from both studies disclosed ties to the pharmaceutical and medical technology industries.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-08-14 12:00
Read more
- Diabetic Women Should Be Asked About Desire For Kids At Every Doctor's Visit, Guidelines Say
- Random Forest AI Model Superior for Inpatient Mortality Prognostication in Cirrhosis
- Regular Exercise Linked to Slower Neurodegeneration in Parkinson Disease
- Magnetic Stimulation, TTNS Both Beat Bladder Training Alone in Overactive Bladder
- Adjusted Mortality Rate Increased for Seniors After Hurricane-Related Flooding
- FDA Requests Sarepta Therapeutics Suspend Distribution of Elevidys and Places Clinical Trials on Hold for Multiple Gene Therapy Products Following Three Deaths
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions